Fernndez-Checa, Liver Unit, Hospital Clnic, Centre Esther Koplowitz, Institut dInvestigacions Biomdiques August Pi i Sunyer (IDIBAPS)Centro de Investigacin Biomdica en Red de Enfermedades Hepticas y Digestivas (CIBERehd), Planta Cuarta, C/Rossell 149, Barcelona 08036, Spain e-mail: [email protected] This article was submitted to Experimental Pharmacology and Drug Discovery, a Section of the journal Frontiers in Pharmacology
If they were truly concerned about long-term costs, theyd be funding these microdosing studies, not blocking coverage
- Monitor your response: Track how your body reacts to the supplements
To overcome these challenges, it is important to understand how our bodies adapt and to come up with effective strategies
Iyengar, S
However, the findings of the SURMOUNT-1 clinical trial from 2022 saw significant weight loss when compared to placebo